FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39706911000001107: Co-beneldopa 12.5mg/50mg dispersible tablets sugar free (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1818681000001116 Co-beneldopa 12.5mg/50mg dispersible tablets sugar free en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1818691000001119 Co-beneldopa 12.5mg/50mg dispersible tablets sugar free (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has specific active ingredient Benserazide hydrochloride true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.oral ontology form and route true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Is a Co-beneldopa true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has active ingredient Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Has active ingredient Levodopa true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Madopar 62.5 dispersible tablets (Roche Products Ltd) Is a True Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablets 100 tablet Has VMP True Co-beneldopa 12.5mg/50mg dispersible tablets sugar free Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start